Stock Scorecard



Stock Summary for Phibro Animal Health Corp - Class A (PAHC) - $41.19 as of 9/12/2025 3:58:26 PM EST

Total Score

16 out of 30

Safety Score

44 out of 100

Currently on the following lists
None
Tim's Recommendation
Possible Buy

Growth List Algorithm Criteria for PAHC

Positive Quarterly and Annual earnings growth
P/E ratio less than Industry P/E Ratio
P/E ratio less than Sector P/E Ratio
P/E ratio that is half the Annual earnings growth rate (or less)
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Positive net income past year and 12 trailing months
Free cash flow ratio greater than 0 and less than 10

Small Cap List Algorithm Criteria for PAHC

Revenue growing by at least 20% average per year over the last 5 years
Market Capitalization under 2 billion
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year

Dividend List Algorithm Criteria for PAHC

Declared an ex-dividend date
Forward annual dividend rate greater than 2
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Current ratio most recent quarter greater than 2
Cash Flow per Share greater than Trailing Dividend Rate

Bonus Criteria for PAHC

P/E ratio less than five-year Average P/E ratio
Last Price to 52 Week Low Ratio Less Than 1
Total Cash Per Share > Last Day Price
P/S Ratio < 1
P/B Ratio < 1

Safety Rating Criteria for PAHC (44 out of 100)

Stock Price Rating (Max of 10) 8
Historical Stock Price Rating (Max of 10) 6
Stock Price Trend (Max of 10) 10
Book Value (Max of 10) 4
Book Value to Price (Max of 10) 0
Analyst Buy Ratings (Max of 5) 0
Analyst Strong Buy Ratings (Max of 5) 3
Dividend Yield Percentage (Max of 10) 1
Operating Margin (Max of 10) 3
Trading Volume (Max of 10) 4
Price to Earnings (Max of 10) 5
Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) 0

Latest News for for PAHC

Exact Sciences Launches Cancerguard MCED Blood Test, Stock Climbs 9/12/2025 12:51:00 PM
Should You Add IDEXX Stock to Your Portfolio Right Now? 9/12/2025 12:48:00 PM
CRL Stock Rises Following New Strategic Oncology Collaborations 9/12/2025 12:44:00 PM
Here's Why You Should Add NVST Stock to Your Portfolio Right Now 9/11/2025 12:25:00 PM
Should You Continue to Hold EXAS Stock in Your Portfolio? 9/10/2025 2:04:00 PM
Phibro Animal Health Corporation ( PAHC ) Hit a 52 Week High, Can the Run Continue? 9/10/2025 1:45:00 PM
Are Investors Undervaluing Phibro Animal Health ( PAHC ) Right Now? 9/10/2025 1:40:00 PM
Here's Why You Should Add PAHC Stock to Your Portfolio Right Now 9/10/2025 1:30:00 PM
ILMN Stock to Gain From the Launch of Illumina Protein Prep Assay 9/9/2025 12:04:00 PM
MYGN Stock Might Gain on The Lancet Study Backing Precise MRD 9/8/2025 12:14:00 PM

Financial Details for PAHC

Company Overview

Ticker PAHC
Company Name Phibro Animal Health Corp - Class A
Country USA
Description Phibro Animal Health Corporation develops, manufactures and supplies a range of mineral nutrition and animal health products for livestock primarily in the United States. The company is headquartered in Teaneck, New Jersey.
Sector Name HEALTHCARE
Industry Name DRUG MANUFACTURERS - SPECIALTY & GENERIC
Most Recent Quarter 6/30/2025
Next Earnings Date 11/5/2025

Stock Price History

Last Day Price 41.19
Price 4 Years Ago 18.33
Last Day Price Updated 9/12/2025 3:58:26 PM EST
Last Day Volume 238,807
Average Daily Volume 353,929
52-Week High 41.57
52-Week Low 16.03
Last Price to 52 Week Low 156.96%

Valuation Measures

Trailing PE 33.29
Industry PE 94.66
Sector PE 41.00
5-Year Average PE 14.21
Free Cash Flow Ratio 12.33
Industry Free Cash Flow Ratio 13.42
Sector Free Cash Flow Ratio 29.67
Current Ratio Most Recent Quarter 2.76
Total Cash Per Share 3.34
Book Value Per Share Most Recent Quarter 7.05
Price to Book Ratio 5.84
Industry Price to Book Ratio 12.22
Sector Price to Book Ratio 32.08
Price to Sales Ratio Twelve Trailing Months 1.24
Industry Price to Sales Ratio Twelve Trailing Months 2.89
Sector Price to Sales Ratio Twelve Trailing Months 19.62
Analyst Buy Ratings 0
Analyst Strong Buy Ratings 1

Share Statistics

Total Shares Outstanding 20,367,600
Market Capitalization 838,941,444
Institutional Ownership 105.02%

Dividends

Ex-Dividend Date 9/3/2025
Previous Dividend Amount 0.1200
Current Dividend Amount 0.1200
Total Years Dividend Increasing 0
Trailing Annual Dividend Rate 0.48
Trailing Annual Dividend Yield 1.21%
Forward Annual Dividend Rate 0.48
Forward Annual Dividend Yield 1.21%
5-Year Dividend Payments Count 20
3-Year Average Dividend Yield 2.32%
5-Year Average Dividend Yield 3.28%
1-Year Dividend Growth Rate Percentage 0.00%
3-Year Dividend Growth Rate Percentage 0.00%
5-Year Dividend Growth Rate Percentage 0.00%
All-Time Dividend Growth Rate Percentage 2.05%
Dividend Payout Ratio 40.34%

Income Statement

Quarterly Earnings Growth YOY 2,191.00%
Annual Earnings Growth 1,897.68%
Reported EPS 12 Trailing Months 1.19
Reported EPS Past Year 2.09
Reported EPS Prior Year 1.19
Net Income Twelve Trailing Months 48,264,000
Net Income Past Year 48,264,000
Net Income Prior Year 2,416,000
Quarterly Revenue Growth YOY 38.60%
5-Year Revenue Growth 10.12%
Operating Margin Twelve Trailing Months 10.10%

Balance Sheet

Total Cash Most Recent Quarter 68,039,000
Total Cash Past Year 68,039,000
Total Cash Prior Year 70,613,000
Net Cash Position Most Recent Quarter -634,396,000
Net Cash Position Past Year -634,396,000
Long Term Debt Past Year 702,435,000
Long Term Debt Prior Year 458,289,000
Total Debt Most Recent Quarter 702,435,000
Equity to Debt Ratio Past Year 0.29
Equity to Debt Ratio Most Recent Quarter 0.29
Total Stockholder Equity Past Year 285,682,000
Total Stockholder Equity Prior Year 256,641,000
Total Stockholder Equity Most Recent Quarter 285,682,000

Free Cash Flow

Free Cash Flow Twelve Trailing Months 41,831,000
Free Cash Flow Per Share Twelve Trailing Months 2.05
Free Cash Flow Past Year 41,831,000
Free Cash Flow Prior Year 46,356,000

Options

Put/Call Ratio 0.40
Has Options Options Chain
Liquidity Rating None

Technical Analysis

Yahoo Finance Chart Yahoo Finance Chart
MACD 3.05
MACD Signal 2.46
20-Day Bollinger Lower Band 16.71
20-Day Bollinger Middle Band 28.08
20-Day Bollinger Upper Band 39.44
Beta 0.88
RSI 77.42
50-Day SMA 23.91
150-Day SMA 17.15
200-Day SMA 17.08

System

Modified 9/13/2025 7:03:56 AM EST